Related Experiment Videos
Palatal myoclonus and opioid peptides
E Martínez-Vila1, P Martínez-Lage Alvarez, M R Luquin
1Department of Neurology, Clínica Universitaria, Medical School, University of Navarra, Pamplona, Spain.
Acta Neurologica Scandinavica
|September 1, 1993
Summary
Palatal myoclonus, a condition causing involuntary palate movements, can occur after anoxic brain damage. Opioid agonists effectively treated this patient's palatal myoclonus, suggesting peptide system involvement.
Area of Science:
- Neuroscience
- Neurology
- Pharmacology
Background:
- Anoxic brain damage can lead to various neurological deficits.
- Palatal myoclonus (PM) is an involuntary movement disorder affecting the soft palate.
Observation:
- A patient developed palatal myoclonus following anoxic brain injury.
- The patient's palatal myoclonus was completely resolved upon administration of opioid agonists.
Findings:
- Opioid agonists demonstrated complete efficacy in abolishing palatal myoclonus in this case.
- The successful treatment suggests a potential role for endogenous opioid or peptide systems in the pathophysiology of PM.
Implications:
- This finding opens new avenues for understanding the neurobiological underpinnings of palatal myoclonus.
- Targeting peptide systems may represent a novel therapeutic strategy for managing PM post-anoxic brain injury.